Literature DB >> 1242563

Synthetic human calcitonin: analysis of antibodies obtained from various animal species and determination of immunoreactive hormone in human sera.

F M Dietrich, W H Hunziker, J A Fischer.   

Abstract

Antibodies to synthetic human calcitonin (hCT) were developed in rabbits, goats and mice. The free peptide (32 amino-acid residues, Mwt. 3418) was administered together with adjuvant, and the effect of various immunization procedures, as well as of different dose-levels, was evaluated comparatively. Synthetic hCT was found to be a good immunogen for the three animal species examined. The relative importance of various structural parts of the hCT molecule with regard to immunological specificity was determined by reference to the inhibition of the specific binding of 125I-hCT to antibodies by peptide fragments of hCT. All the antisera studied were directed to structural and/or conformational properties of the 11-28 or 11-32 amino acid sequence of hCT. Six different antisera from rabbits and goats were selected for radioimmunological assay of hCT on the basis of their inhibitory dose50-values and immunological specificity. To improve the sensitivity of the radioimmunoassay (RIA), we studied the preparation of radioiodinated hCT and assessed various parameters determining the sensitivity of the assay. Despite all the efforts, CT in human plasma from healthy subjects could not be determined with certainty. The difficulties encountered in the determination of normal levels of circulating CT are discussed in terms of the sensitivity of RIA and non-specific interference of serum factors with RIA.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1242563     DOI: 10.1530/acta.0.0800465

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  10 in total

1.  Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of postmenopausal osteoporosis.

Authors:  R Muff; M A Dambacher; J A Fischer
Journal:  Osteoporos Int       Date:  1991-02       Impact factor: 4.507

2.  Monoclonal antibodies against calcitonin. Characterization and application in light and electron microscopy immunocytochemistry.

Authors:  L Scopsi; J Arias; G Houen; G Racchetti; G L Fossati; Y M Galante
Journal:  Histochemistry       Date:  1988

3.  Calcitonin and calcium ionophores: cyclic AMP responses in cells of a human lymphoid line.

Authors:  J Moran; W Hunziker; J A Fischer
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

4.  Acute oral alkali citrate load in healthy humans--response of blood and urinary citrate, mineral metabolism, and factors related to stone formation.

Authors:  P O Schwille; J H Weippert; W Bausch; G Rümenapf
Journal:  Urol Res       Date:  1985

5.  Regulation of circulating parathyroid hormone levels: normal physiology and consequences in disorders of mineral metabolism.

Authors:  J A Fischer; J W Blum; W Hunziker; U Binswanger
Journal:  Klin Wochenschr       Date:  1975-10-15

6.  Calcitonin: regional distribution of the hormone and its binding sites in the human brain and pituitary.

Authors:  J A Fischer; P H Tobler; M Kaufmann; W Born; H Henke; P E Cooper; S M Sagar; J B Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

7.  Hypercalcitoninaemia in patients with pheochromocytoma.

Authors:  F Raue; J M Bayer; K H Rahn; C Herfarth; H Minne; R Ziegler
Journal:  Klin Wochenschr       Date:  1978-07-15

8.  Intracolonic bioavailability of human calcitonin in man.

Authors:  C Beglinger; W Born; R Muff; J Drewe; J L Dreyfuss; A Bock; M Mackay; J A Fischer
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

9.  Histologic characteristics of insulinomas and gastrinomas. Value of argyrophilia, metachromasia, immunohistology, and electron microscopy for the identification of gastrointestinal and pancreatic endocrine cells and their tumors.

Authors:  W Woodtli; C Hedinger
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-10-07

10.  Effects of calcium and calcitonin on circulating levels of glucagon and glucose in diabetes mellitus.

Authors:  A Starke; E Keck; M Berger; H Zimmermann
Journal:  Diabetologia       Date:  1981-05       Impact factor: 10.122

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.